The aetiological relationship between lung cancer and chronic obstructive lung disease is still controversial. The main causal factor in lung cancer, tobacco smoking, is also a prominent cause of both chronic bronchitis and chronic obstructive lung disease. ' The group of patients with chronic cardiopulmonary disease, considered as whole, showed a fiveyear survival of 35%, compared with 53% of patients without cardiopulmonary risk; but the difference was not statistically significant (p = 0-08- fig 2) . On the other hand, the age of patients significantly affected survival (for age under 60 ver- sus 60 or over p < 0.025); but sex, tumour extent, and volume of resection if considered by themselves had no significant effect on survival. The effect of cardiopulmonary risk was then stratified for age. Table 2 shows the numbers of patients, deaths, and deaths due to recurrence of the tumour according to age and the presence of cardiopulmonary risk. An appreciable difference in survival by age and risk appeared only in the group of patients under 60 years (fig 3) , though not significant (p < 0-12), while over 60 the presence of cardiopulmonary risk did not result in a lower survival rate. From a statistical point of view, the effect of chronic disease was reduced by age standardisation (age standardised p = 0.215). This fact suggests that the observed difference in survival according to cardiopulmonary risk was partly attritutable to the age of patients. The relation between risk and volume of resection was also examined. Major resections did not appear to have a significantly greater effect on survival in patients at cardiopulmonary risk than the lesser resections, and even in the less favourable conditions the observed survival exceeded 30% (for example, cardiopulmonary risk and pneumonectomy in patients over 60, 33%). Nevertheless, if we consider at risk only those patients with cardiopulmonary disease who also had a pneumonectomy or were over 60, the overall difference in survival increased and became significant (30% v 52%, p < 0.025). The role of cardiopulmonary disease was then evaluated on the basis of the survival curves for separate causes of death. Figure 4 shows the noncancer mortality according to the preoperative risk, where all patients who had died from cancer recurrence were considered as lost to follow-up; survival rates were 88% and 65% (p < 0.025). Separate analysis of the effect of chronic pulmonary disease showed that this had a lesser impact on survival, though all the perioperative deaths occurred in this group, thus confirming the lack of importance of cardiovascular disease as a component of the postoperative risk. Unfortunately, a more detailed analysis of this subject was not possible owing to our small sample. The exclusion of operative mortality greatly reduced the difference in survival on all the curves, thus indicating that the role of chronic cardiopulmonary disease was mainly attributable to the higher operative mortality. Nevertheless, the difference between the groups remained significant for non-cancer deaths and also when further risk factors, such as age over 60 or pneumonectomy, were added to cardiopulmonary disease. 
